Container Closure Integrity Testing (CCIT) is a critical part of sterile product development because the package must protect the formulation from moisture, oxygen, microbial ingress, and physical stress throughout storage, transport, and use. For drug developers working with vials, prefilled syringes, cartridges, ampoules, blow-fill-seal units, and flexible systems, the challenge is rarely just finding a leak test. The real need is selecting a fit-for-purpose method, generating defensible data for the actual product-package configuration, and understanding how closure design, fill conditions, headspace, and handling affect long-term package performance. BOC Sciences provides end-to-end CCIT services supported by integrated analytical development and quality control capabilities, helping clients make faster, more confident decisions during development, scale-up, comparability assessment, and commercial support.
We build a product-specific testing strategy by matching the leak detection approach to package format, formulation behavior, headspace profile, and development objectives.
Our CCIT platform supports sensitive, quantitative evaluation of primary container systems used for sterile drug products and advanced formulations.
Leak integrity is only part of package performance. We also characterize closure behavior, gas and moisture changes, and package attributes that influence long-term reliability through our broader analytical platform.
When integrity questions appear late in development or during manufacturing, rapid technical interpretation matters as much as the test itself. We help clients turn CCIT data into practical next actions.
BOC Sciences helps drug developers choose the right integrity strategy, generate meaningful leak data, and reduce package-related development risk across complex sterile products.
A robust non-destructive technique for detecting leakage in rigid and semi-rigid containers by measuring pressure changes under controlled vacuum conditions. It is especially valuable for routine comparison of vials, cartridges, bottles, and selected syringe systems.
This non-destructive method is highly effective for conductive liquid-filled products, using electrical property changes to reveal defects at the container wall, stopper, seal, or plunger interface without opening the package.
For demanding applications requiring very high analytical sensitivity, helium-based approaches support detailed assessment of package tightness and are particularly useful during method development, component screening, and difficult failure investigations.
Headspace oxygen and moisture monitoring helps assess whether package integrity is sufficient to protect sensitive formulations such as lyophilized biologics, oxidation-prone solutions, and products exposed to demanding storage conditions.
We assess residual seal force, closure compression behavior, and component fit to understand how vial-stopper-seal systems evolve over time and where performance margins may narrow under real packaging stresses.
Meaningful method evaluation depends on realistic positive controls. We design defect models and challenge studies that better reflect likely leak pathways and help clients understand true method capability for their package system.
BOC Sciences supports container closure integrity studies for a wide range of sterile dosage forms and primary packaging systems. Our team adapts the study design to the geometry, material, closure mechanism, headspace profile, and product behavior of each package rather than relying on a one-method-fits-all model.
Share your container format, formulation type, closure components, and project stage. Our scientists will recommend a practical integrity testing strategy tailored to your specific product-package risks.
We begin by reviewing the package design, closure interfaces, formulation properties, fill volume, headspace characteristics, and intended storage conditions to identify likely leak paths and the most relevant integrity risks.
Our team selects and configures suitable test technologies, prepares realistic controls, and defines the study scope for feasibility, package comparison, stress evaluation, or failure investigation according to your development question.
We execute the CCIT studies under controlled conditions, analyze package-specific performance trends, and distinguish closure-related integrity loss from method artifacts or product effects that can complicate interpretation.
Clients receive a clear technical report with data interpretation, package risk conclusions, and practical recommendations for component selection, closure settings, stress studies, or next-stage lifecycle support.
Freeze-dried presentations can fail long before a visible seal defect appears. BOC Sciences helps clients evaluate whether closure integrity is sufficient to protect low-moisture products during storage, shipping, and repeated temperature changes, combining leak testing with package-relevant moisture and oxygen assessments.
Prefilled syringes and cartridges involve multiple sealing surfaces, moving components, and device-related mechanical stresses. We build test strategies that look beyond a single closure point and assess how plunger fit, tip-cap movement, and assembly conditions affect overall package integrity.
Package performance can shift over time as closure force relaxes or storage conditions challenge the system. Our CCIT studies are often paired with broader stability studies so clients can understand integrity behavior across the full product lifecycle rather than at a single time point.
A failed integrity result does not always mean the container is fundamentally unsuitable. We help determine whether the issue is driven by package assembly, component variability, formulation effects, unrealistic challenge conditions, or true leak behavior, enabling faster and more focused follow-up decisions.
Partner with BOC Sciences for data-driven container closure integrity studies that connect leak detection results to real product, package, and lifecycle decisions.
We match the test approach to your actual package configuration, formulation behavior, and development objective rather than forcing a generic method onto every study.
Our scientists can compare complementary CCIT technologies and supporting analyses to provide a fuller picture of closure performance, package tightness, and likely failure mechanisms.
We do more than report pass-or-fail outcomes. Our studies help clients understand how package integrity may evolve with stress, storage, component changes, and process transfer.
For teams also advancing sterile dosage forms, BOC Sciences can align CCIT work with broader formulation development goals to support smarter package and product decisions in parallel.
Client Needs: A client developing a lyophilized Fc-fusion protein in a 10 mL stoppered vial needed to understand whether the selected stopper-seal combination could maintain package tightness after accelerated handling and long-term low-moisture storage.
Challenges: The formulation was highly sensitive to headspace changes, while the vial system showed inconsistent closure behavior after capping adjustments. The client needed data that connected leak performance with real package attributes rather than a single screening result.
Solution: BOC Sciences designed a study combining vacuum decay screening, headspace oxygen tracking, and residual seal force assessment across multiple capping conditions and component lots. We also built package-specific positive controls to verify method responsiveness at critical closure interfaces.
Outcome: The study identified a closure setup window that improved consistency, reduced uncertainty around seal behavior over time, and supported a more confident vial-stopper-seal selection for the client's next development stage.
Client Needs: A biotech team working on a high-concentration GLP-1 analog in a prefilled syringe required a package comparison study to assess integrity performance across two plunger formulations and two rigid needle shield designs.
Challenges: The viscous liquid product and multiple syringe sealing interfaces complicated method selection and data interpretation. The client needed to know whether observed differences came from true package performance or from package-component mechanics during testing.
Solution: We developed a multi-part strategy using high-voltage leak detection for filled-syringe evaluation together with closure-interface review and comparative stress handling. The study design focused on tip-cap movement, plunger-related sealing behavior, and lot-to-lot package consistency.
Outcome: BOC Sciences identified the stronger component combination, clarified the most sensitive syringe interfaces, and delivered practical guidance for narrowing the final syringe configuration before broader scale-up work.
Client Needs: A developer of preservative-free ophthalmic unit-dose products needed integrity support for a blow-fill-seal presentation intended to protect a small-molecule anti-inflammatory formulation from storage- and transport-related leakage risk.
Challenges: The package geometry required a tailored fixture strategy, and the team needed to distinguish seal weakness from stress introduced during handling simulations. Off-the-shelf assumptions were not sufficient for this container format.
Solution: BOC Sciences established a customized CCIT workflow that paired feasibility testing with stress-condition comparisons and package-specific control design. We evaluated the influence of molded seal zones, fill behavior, and handling conditions on integrity performance.
Outcome: The project generated a clearer understanding of the most vulnerable seal regions, supported packaging optimization, and gave the client a practical roadmap for follow-up verification studies on the final BFS configuration.
Container Closure Integrity Testing, or CCIT, evaluates whether a drug container and its closure can maintain an effective barrier against leaks, gas exchange, moisture ingress, or unwanted external contamination. It focuses on the complete product-package system, not only the container material. For drug developers, CCIT helps confirm that vials, syringes, cartridges, ampoules, bags, or other packaging formats remain suitable for protecting sensitive formulations during development, storage, handling, and use-condition simulation.
CCI testing is important because packaging failure can compromise product performance even when the formulation itself is well designed. During development, CCIT helps teams understand whether closure design, fill level, headspace, material selection, assembly parameters, and storage conditions may create leakage risks. BOC Sciences can support this decision-making through integrated analytical development, stability-related evaluation, packaging compatibility assessment, and sterile manufacturing process support, helping clients connect formulation behavior with container performance.
The best CCIT method depends on the container format, formulation properties, headspace, closure design, material conductivity, and the type of leak risk being investigated. Deterministic methods such as vacuum decay, laser-based headspace analysis, and high-voltage leak detection can provide objective, measurable results, while other approaches may be useful for screening or specific package types. BOC Sciences can help clients evaluate product-package characteristics and design practical analytical strategies instead of relying on a one-size-fits-all method.
Yes. CCIT can be applied to many nonporous and semi-rigid package formats, including glass vials, ampoules, prefilled syringes, cartridges, flexible bags, pouches, bottles, and certain drug-device combination presentations. Each format may require a different fixture, sample preparation approach, or detection technology because leak paths and closure interfaces vary. BOC Sciences’ experience with multiple container closure systems, packaging compatibility evaluation, and automated container closure testing can help clients assess packaging choices across development programs.
CCIT guides packaging risk decisions by showing whether a container closure system can maintain barrier performance under realistic product and handling conditions. The results can help teams compare packaging options, investigate unexpected failures, refine sealing parameters, evaluate storage stresses, and decide whether additional method development is needed. For drug developers, a strong CCIT strategy is not just a final check; it is a practical tool for reducing late-stage packaging surprises and improving confidence in product-package compatibility.
BOC Sciences did not just provide leak test numbers. Their team helped us understand which vial-stopper-seal combination actually gave us a stronger performance window and why. That clarity saved substantial rework in our package selection phase.
— Dr. Laura T., Director of Pharmaceutical Development
Our prefilled syringe program involved multiple closure interfaces and conflicting internal data. BOC Sciences built a sensible testing strategy, interpreted the results carefully, and gave our team a much better basis for deciding between component options.
— Dr. Michael, Senior CMC Manager
When an unexpected integrity signal appeared in our study, their scientists worked through the package mechanics and method behavior with real technical depth. The outcome was a focused action plan instead of another round of guesswork.
— Dr. Nina P., Principal Scientist, Sterile Products
What stood out most was their ability to connect CCIT data with long-term package performance. The recommendations were practical, detailed, and clearly written for a development team that needed to move forward quickly and confidently.
— James C., Head of Technical Operations
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
